iwNHL 2016 highlights: CAR T-cell therapy, DLBCL and new technologies
Update on the clinical management of diffuse large B-cell lymphoma
Christian Gisselbrecht et al.
The evolving genomic landscape of acute lymphoblastic leukemia (ALL): subtypes, genes and targets
New subtypes of acute lymphoblastic leukemia (ALL) – potential treatment identification by genomics
The potential clinical implications of targeted therapies for DLBCL and why the situation is complex